We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

A Call for New Thoughts About What Might Influence Human Brain Aging Aging, Apolipoprotein E, and Amyloid

Charles DeCarli, MD1
[+] Author Affiliations
1Department of Neurology and Center for Neuroscience, University of California at Davis, Sacramento
JAMA Neurol. 2015;72(5):500-502. doi:10.1001/jamaneurol.2015.33.
Text Size: A A A
Published online


As a greater proportion of the world’s population live beyond age 65 years, there is increasing awareness of age-related differences in cognitive ability and a rising interest in finding ways to maintain healthy brain aging with the hope to avoid dementia. Although conventional wisdom stresses the inevitable decline of cognitive ability with age, seminal work by Wilson et al1 finds that individual trajectories of cognitive ability vary greatly, suggesting that at least some of the age-related differences in cognitive ability are due to incipient disease. Conventional wisdom also stresses that incipient or clinically expressed Alzheimer disease (AD) explains most cognitive decline and incident dementia among older individuals. The negative impact of incipient AD on cognitive ability among apparently cognitively normal older individuals is further supported by the long prodromal period of the AD process. The advent of in vivo amyloid imaging (and even eventually tau imaging) has stimulated intense interest regarding the role of incipient AD in relationship to cognitive aging. Early reports suggest a strong relationship between memory performance and cortical amyloid retention in a group of individuals with various degrees of cognitive ability. Later studies also found that increased cerebral amyloid burden, which is highly associated with age and the apolipoprotein E ε4 (APOE ε4) genotype2 among cognitively normal individuals, is associated with subtle declines in cognitive performance3 and increased risk for future dementia.4 This work and the increasing availability of biological markers of AD pathology have led to a proposed biological cascade model of AD5 and reevaluation of diagnostic criteria for AD.6 If one ascribes religiously to the concept that a large proportion of cognitive differences with age are driven by incipient disease, then one might expect that memory performance—a cognitive ability that changes most dramatically with age and is common to AD—would follow increasing levels of associated cerebral amyloid and be strongly associated with hippocampal atrophy. In their article, Jack et al7 present new information that challenges the notion that amyloid accumulation explains memory performance across the entire age range. Importantly, this work does not only address the likely highly significant impact of cerebral amyloid accumulation on dementia risk, but also extends current knowledge relating to the impact of the aging process across the spectrum of ages 30 to 95 years to brain structure, amyloid accumulation, and memory performance among cognitively normal individuals.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Falls, Older Adults

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Quick Reference